Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
Congress Acts to End PAMA Price Cutting Reign of Terror
After years of resistance, the lab industry’s hopes and prayers for relief from the flawed pricing scheme may soon be answered.
6 Key Items in CMS’ Proposed 2023 Physicians Fee Schedule
Changes to PAMA reporting timelines and requirements, as well as payment cuts, are just some of the main takeaways labs should know about.
15 Doctors Pay $2.8 Million to Settle Lab Referral Kickback Allegations
A total of 33 doctors have now paid settlements in relation to an alleged lab testing referrals scheme, according to the DOJ.
Recent Studies Show Promise of AI and Wearables for COVID-19 Screening
Research shows that AI algorithms trained with data collected from wearable devices were effective in identifying COVID-19.
Liquid Biopsy Can Rule Out Need for Chemotherapy After Stage II Colon Cancer Surgery
New study shows that ctDNA liquid biopsy testing after stage II colon cancer may determine whether chemotherapy is required.
Theranos In Court: Balwani Convicted on All Counts
The former Theranos CEO was found guilty of 10 ten counts of wire fraud and two counts of conspiracy to commit wire fraud.
As Concern Over Monkeypox Grows, Testing Expands in US
Labcorp begins offering CDC’s PCR test for orthopoxviruses, including monkeypox, with plans to further expand testing capacity.
Blood-Based Tests Can Detect Early-Stage Lung Cancer
Team creates a mass spectrometry-based blood lipid test that, when combined with AI, identifies early signs of the disease.
National HCFAC Program Health Fraud Recoveries Top $5 Billion
According to a recently released report, in FY 2021, of 831 new criminal healthcare fraud investigations, 312 resulted in convictions.
Carolina Lab Owners Shell Out $6 Million to Settle FCA Charges
Owners of now defunct Physicians Choice Laboratory Services were accused of paying kickbacks to physicians to order tests from the lab.